Agios Pharmaceuticals: Q3 Earnings Snapshot
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $91.3 million in its third quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $1.64.
The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.69 per share.
The biopharmaceutical company posted revenue of $7.4 million in the period, which did not meet Street forecasts. Five analysts surveyed by Zacks expected $7.7 million.
Agios Pharmaceuticals shares have dropped 24% since the beginning of the year. The stock has decreased 25% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGIO at https://www.zacks.com/ap/AGIO
